health π©Ί India's diabetes cases set to jump 73% by 2050
Diabetes cases in India are projected to surge by 73% by 2050, affecting over 150 million people. Experts highlight that GLP-1 therapies are changing Type 2 diabetes management in India. The rising burden is due to aggressive progression and late diagnosis in Indian populations. Quality in these complex peptide medicines relies on rDNA technology and rigorous manufacturing. Expanding access must match high-quality, science-backed prescribing for better outcomes. π©Ί